Barclays’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-149,583
Closed -$6.43M 4243
2015
Q3
$6.43M Hold
149,583
0.01% 619
2015
Q2
$6.28M Sell
149,583
-26,189
-15% -$1.1M 0.01% 721
2015
Q1
$6.68M Sell
175,772
-24,561
-12% -$933K 0.01% 781
2014
Q4
$6.61M Buy
200,333
+15,368
+8% +$507K 0.01% 798
2014
Q3
$6.47M Buy
184,965
+59
+0% +$2.07K 0.01% 844
2014
Q2
$5.92M Buy
184,906
+52,136
+39% +$1.67M 0.01% 871
2014
Q1
$4.78M Buy
132,770
+63,086
+91% +$2.27M 0.01% 947
2013
Q4
$2.65M Buy
69,684
+27,284
+64% +$1.04M ﹤0.01% 1262
2013
Q3
$1.15M Buy
42,400
+26,800
+172% +$724K ﹤0.01% 1621
2013
Q2
$328K Buy
+15,600
New +$328K ﹤0.01% 2450